Advertisement
BDX vs SOLV
Which Stock Would AI Choose? Becton, Dickinson and Company (BDX) vs. Solventum Corporation (SOLV) Stock Comparison
Key Takeaways
- Becton, Dickinson and Company (BDX) operates as a large-cap medical technology leader with diversified exposure across diagnostics, devices, and biopharma solutions, while Solventum Corporation (SOLV) focuses on specialized healthcare products spun off from a larger conglomerate.
- Recent market activity shows BDX trading near $165 with relatively stable performance amid broader sector trends, whereas SOLV has hovered around $85 following its independent listing, reflecting different maturity stages in the healthcare space.
- Both companies face sector headwinds including regulatory scrutiny and supply chain dynamics, but BDX benefits from established global scale and recurring revenue streams compared to SOLV’s growth-oriented positioning.
- Market sentiment for BDX has remained consistent due to its defensive healthcare profile, while SOLV exhibits higher volatility typical of recently independent entities adjusting to standalone operations.
- Relative performance in recent weeks highlights trade-offs between BDX’s size-driven stability and SOLV’s potential for focused innovation in patient care solutions.
- Investors comparing the two often weigh BDX’s dividend history and broad portfolio against SOLV’s narrower product focus and evolving financial structure.
Introduction
Becton, Dickinson and Company (BDX) and Solventum Corporation (SOLV) represent two distinct players in the medical technology and healthcare solutions sector. This comparison examines their business models, recent stock behavior, and relative positioning to assist investors and traders evaluating exposure within healthcare equities. The analysis draws on observable market data and company fundamentals to highlight contrasts in scale, growth drivers, and risk profiles. Market participants seeking defensive healthcare holdings or opportunities in specialized medical products may find this side-by-side review useful for portfolio construction decisions in the current environment.
BDX Overview and Recent Performance
Becton, Dickinson and Company (BDX) is a global medical technology firm with operations spanning medical essentials, connected care, biopharma systems, and interventional solutions. The company serves healthcare providers worldwide through a broad portfolio of devices, instruments, and reagents. In recent market activity, BDX shares have traded in a range around $165, supported by its established market position and recurring revenue from essential medical products. Performance in recent weeks has reflected steady institutional interest amid sector rotation, with influences including quarterly earnings updates and broader macroeconomic factors affecting healthcare spending. Sentiment has remained measured, bolstered by the company’s scale and diversification across multiple therapeutic areas.
SOLV Overview and Recent Performance
Solventum Corporation (SOLV) is a healthcare company that develops, manufactures, and commercializes solutions addressing critical patient and customer needs in hospital and clinical settings. Spun off to operate independently, SOLV maintains a focused portfolio in medical products. Recent market activity has seen SOLV shares trading near $85, with performance reflecting the transition to standalone status and integration of its operations. In recent weeks, price movements have been influenced by sector-wide trends and company-specific updates on revenue streams. Sentiment has shown variability typical of newly listed entities, with attention on execution of growth strategies and margin management in a competitive landscape.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available across the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and risk parameters, but only those demonstrating strong suitability for prevailing market conditions are featured in the trending section. Available bots display a range of performance metrics, win rates, and drawdown statistics that help users evaluate fit for different market environments. The platform offers diverse trading styles from short-term momentum approaches to longer-horizon trend-following methods. Review the Trending AI Robots page for current selections and detailed bot statistics.
Head-to-Head Comparison
Becton, Dickinson and Company (BDX) and Solventum Corporation (SOLV) operate in overlapping healthcare segments but differ markedly in scale and structure. BDX maintains a larger global footprint with diversified revenue across multiple platforms, providing greater stability through established customer relationships and product breadth. SOLV, as a more focused entity, emphasizes targeted solutions in patient care but carries the execution risks associated with its recent separation and building of independent infrastructure. Recent momentum for BDX has been steadier due to its defensive characteristics, while SOLV has shown sensitivity to post-spin-off adjustments. Risk factors include regulatory and reimbursement pressures for both, though BDX’s size offers some buffer compared to SOLV’s concentrated exposure. Sector sentiment remains supportive of healthcare innovation, yet market positioning favors BDX for income-oriented investors and SOLV for those seeking potential upside from specialized growth initiatives.
Tickeron AI Verdict
Based on observable factors such as trend consistency, business stability, and relative sector positioning, Tickeron’s AI would currently assign a probabilistic edge to Becton, Dickinson and Company (BDX) over Solventum Corporation (SOLV). The established scale and diversified operations of BDX contribute to more consistent performance patterns, whereas SOLV’s newer independent structure introduces additional variables in momentum assessment. This assessment remains conditional on evolving market data and does not constitute a definitive recommendation.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and SOLV is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDX’s FA Score shows that 2 FA rating(s) are green whileSOLV’s FA Score has 1 green FA rating(s).
- BDX’s FA Score: 2 green, 3 red.
- SOLV’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDX’s TA Score shows that 5 TA indicator(s) are bullish while SOLV’s TA Score has 5 bullish TA indicator(s).
- BDX’s TA Score: 5 bullish, 4 bearish.
- SOLV’s TA Score: 5 bullish, 4 bearish.
Price Growth
BDX (@Pharmaceuticals: Other) experienced а +3.70% price change this week, while SOLV (@Pharmaceuticals: Other) price change was +6.76% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.24%. For the same industry, the average monthly price growth was +7.38%, and the average quarterly price growth was +3.68%.
Reported Earning Dates
BDX is expected to report earnings on Nov 05, 2026.
SOLV is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+0.24% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| BDX | SOLV | BDX / SOLV | |
| Capitalization | 50B | 15.1B | 331% |
| EBITDA | 4.97B | 2.49B | 199% |
| Gain YTD | 21.791 | 11.800 | 185% |
| P/E Ratio | 31.73 | 10.83 | 293% |
| Revenue | 22.2B | 8.26B | 269% |
| Total Cash | N/A | 561M | - |
| Total Debt | 17.3B | 5.29B | 327% |
BDX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 34 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 89 | |
SMR RATING 1..100 | 86 | |
PRICE GROWTH RATING 1..100 | 11 | |
P/E GROWTH RATING 1..100 | 62 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BDX | SOLV | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 61% | 4 days ago 50% |
| Stochastic ODDS (%) | 4 days ago 46% | 4 days ago 57% |
| Momentum ODDS (%) | 4 days ago 50% | 4 days ago 67% |
| MACD ODDS (%) | 4 days ago 51% | 4 days ago 43% |
| TrendWeek ODDS (%) | 4 days ago 47% | 4 days ago 67% |
| TrendMonth ODDS (%) | 4 days ago 50% | 4 days ago 72% |
| Advances ODDS (%) | 6 days ago 44% | 4 days ago 66% |
| Declines ODDS (%) | 26 days ago 43% | 13 days ago 60% |
| BollingerBands ODDS (%) | 4 days ago 50% | 4 days ago 44% |
| Aroon ODDS (%) | 4 days ago 51% | 4 days ago 72% |
Advertisement
BDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.
| Ticker / NAME | Correlation To BDX | 1D Price Change % | ||
|---|---|---|---|---|
| BDX | 100% | +0.79% | ||
| COO - BDX | 54% Loosely correlated | -0.56% | ||
| BAX - BDX | 51% Loosely correlated | -1.18% | ||
| TMO - BDX | 50% Loosely correlated | -1.28% | ||
| CNMD - BDX | 48% Loosely correlated | +1.18% | ||
| SOLV - BDX | 47% Loosely correlated | +2.46% | ||
More | ||||
SOLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with BAX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then BAX could also see price increases.
| Ticker / NAME | Correlation To SOLV | 1D Price Change % | ||
|---|---|---|---|---|
| SOLV | 100% | +2.46% | ||
| BAX - SOLV | 49% Loosely correlated | -1.18% | ||
| RMD - SOLV | 46% Loosely correlated | -1.01% | ||
| NVST - SOLV | 45% Loosely correlated | -0.04% | ||
| COO - SOLV | 44% Loosely correlated | -0.56% | ||
| BDX - SOLV | 44% Loosely correlated | +0.79% | ||
More | ||||